Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 14 (2), 114-120

Summary of 2185 Prenatal Invasive Procedures in a Single Center: A Retrospective Analysis

Affiliations

Summary of 2185 Prenatal Invasive Procedures in a Single Center: A Retrospective Analysis

Hüseyin Çağlayan Özcan et al. Turk J Obstet Gynecol.

Abstract

Objective: To determine the frequency, indications, and outcomes of diagnostic invasive prenatal procedures (DIPP) performed in a university hospital.

Materials and methods: This retrospective, observational study included 2185 cases of DIPP (chorionic villus sampling, amniocentesis, and cordocentesis) performed at the department of obstetrics and gynecology of a university hospital between 2010 and 2016. We included all DIPP cases performed between 11 and 24 weeks of gestation. We compared the different types of DIPP performed in our hospital.

Results: Two thousand one hundred eighty-five procedures were performed (1853 amniocenteses, 326 chorionic villus sampling, and 6 cordocenteses). The main indication for performing invasive procedures was abnormal results of aneuploidy screening for trisomy 21, followed by maternal age, and fetal structural abnormality. The fetal karyotype was altered in 154 (26.1%) cases. Trisomy 21 was the most common aneuploidy followed by trisomy 18, monosomy X, and trisomy 13. Fetal karyotype could not be revealed in 42 (2%) cases due to maternal contamination in 18 cases, inadequate sampling in 4 cases, and failure of cell culture in 27 cases. There were 2 pregnancy losses due to the invasive procedure (only in amniocentesis).

Conclusion: The ideal approach to pregnancies with a detected chromosomal abnormality should be tailored according to the individual choice of the couples regarding whether they decide for or against a child with a known chromosomal abnormality.

Keywords: Amniocentesis; chorionic villus sampling; cordocenteses; prenatal genetic diagnostic testing.

Conflict of interest statement

Conflict of Interest: No conflict of interest was declared by the authors.

Similar articles

See all similar articles

Cited by 1 article

References

    1. Borrell A, Casals E, Fortuny A, Farre MT, Gonce A, Sanchez A, et al. First-trimester screening for trisomy 21 combining biochemistry and ultrasound at individually optimal gestational ages. An interventional study. Prenat Diagn. 2004;24:541–5. - PubMed
    1. Spencer K, Spencer CE, Power M, Dawson C, Nicolaides KH. Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years prospective experience. BJOG. 2003;110:281–6. - PubMed
    1. Norton ME, Rink BD. Changing indications for invasive testing in an era of improved screening. Semin Perinatol. 2016;40:56–66. - PubMed
    1. Gardner RJ. Chromosome Abnormalities and Genetic Counseling, 3rd ed NewYork. NY: Oxford University Press. 2004
    1. American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins-Obstetrics; Committee on Genetics; Society for Maternal-Fetal Medicine. Practice Bulletin No. 162: Prenatal Diagnostic Testing for Genetic Disorders. Obstet Gynecol. 2016;127:e108–22. - PubMed

LinkOut - more resources

Feedback